Navigation Links
Forgetfulness Actually Helps Your Brain Stay Healthy

People who have a tendency for forgetting things are the ones with the last laugh, for researchers have found that a forgetfulness is a sign that your brain is working properly.

Researchers led by Brice Kuhl at Stanford University in California, US, conducted a study on the brain and found that the brain only chooses to remember memories that it deems important.

This is done by suppressing the memories that the brains thinks are less relevant, thus lessening its cognitive load, and preventing confusion.

"Whenever youre engaging in remembering, the brain adapts. Its constantly re-weighting memories," the New Scientist quoted Kuhl, as stating.

"In this simple test, we see it reverse memory to weaken competing memories. This is something that probably happens a lot in the real world," he added.

As a part of the study, that appears in Nature magazine, the researchers used functional magnetic resonance imaging (fMRI) to measure the brain activity of 20 healthy adults as they performed a simple memory test.

The test included memorising three pairs of words, two of which were closely associated. These pairs were: ATTIC dust, ATTIC junk and MOVIE reel.

After studying "ATTIC dust" twice, the participants were asked to recall all three pairs using the first words as cues.

The researchers found that on an average, people were better at recalling the unrelated pair MOVIE junk, than ATTIC junk.

When the researchers compared the findings to the fMRI data taken during the test, they found that the brains of the participants was highly active in a region known for handling competing memories, which is also an area believed to induce memory suppression.

They now believe that the first region in the brain identified "ATTIC dust" and "ATTIC junk" as conflicting memories, leading to the second region to suppress "ATTIC junk" as it had only been s
'"/>




Page: 1 2

Related medicine news :

1. Cancer Patients Might Be Able To Actually Help Themselves
2. Calcium Supplementation May Not Actually Prevent colon cancer say researchers
3. Single Women with Baby Cravings Can Actually Cradle their Own, Courtesy NHS
4. Does Life Saving Stents Actually Carry The Risk Of Blood Clots?
5. When Teens Actually Want to Become Mothers
6. Gene Thought to Help Kill Cancer Cells may Actually Help Them Thrive
7. Fly Ash Bricks are Absolutely Safer Than Actually Predicted
8. Antibiotics Helps Autism
9. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
10. Prescription Drug - Helps People Stop Smoking
11. New Drug PP188 Helps Sickle Cell Disease
Post Your Comments:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3AMD LASERS Announces Partnerships With Three Industry Leading Companies 5686 1Keryx Biopharmaceuticals Inc Announces Upcoming Poster Presentation of Zerenex 28ferric citrate 29 for the Treatment of Hyperphosphatemia at the Up 5683 1Keryx Biopharmaceuticals Inc Announces Upcoming Poster Presentation of Zerenex 28ferric citrate 29 for the Treatment of Hyperphosphatemia at the Up 5683 2Keryx Biopharmaceuticals Inc Announces Upcoming Poster Presentation of Zerenex 28ferric citrate 29 for the Treatment of Hyperphosphatemia at the Up 5683 3Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 1Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 2
Other Medicine Technology:New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7